Are you in a crisis? Call or text 988 to speak to a crisis counselor.

From Behavioral Health Business: Psychedelics Must Be Based in ‘Traditional Psychiatric’ Care

For all the hype, psychedelics such as MDMA or psilocybin won’t succeed as a treatment or service line without substantial clinical support within behavioral health organizations. As recent ketamine provider stumbles, simply establishing access to and attempting to scale singular forms of treatment tend to lead to failure. Further, such treatment-specific ventures fail to address the holistic nature of health and the fragmented reality of the American health care system.

“It’s proven there’s a demand for effective treatments considering the traditional treatments have always suffered from poor efficacy rates...The field needs new treatments that are effective. And I think that part of it is getting widely accepted — that there are new ways to approaching this.”

1200 628 Taylor Carter

Taylor Carter

Taylor Carter is a dynamic Senior Marketing Manager with a passion for crafting compelling narratives and driving impactful campaigns. She has been an integral part of the Hopemark Health team for the past two years. By combining industry insights and medical facts with a deep understanding of the patient experience, Taylor continuously seeks to uplift and empower individuals on their journey to well-being.

Article by: Taylor Carter